Knopp Biosciences Presents New Phase 2 Data at AAAAI 2022 Demonstrating That Oral Dexpramipexole Improves Airflow Obstruction as Measured by Forced Expiry Volume (FEV1), Largely Through Its Effect on Forced Vital Capacity (FVC)
Poster concludes that change in FEV1 was correlated with change in blood absolute eosinophil count (AEC), demonstrating the link between eosinophil depletion and clinical benefit Knopp...